| Authors: |
Mahoney-Crane CL; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Viswanathan M; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Russell D; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Curtiss RAC; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Freire J; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Bobba SS; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Coyle SD; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294., Kandebo M; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Yao L; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Wan BL; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Hatcher NG; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Smith SM; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Marcus JN; Neuroscience Discovery, Merck & Company, Inc, West Point, Pennsylvania 19486., Volpicelli-Daley LA; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294 lvolpicellidaley@uabmc.edu. |